SCHEMBL17488648

SCHEMBL17488648

Cc1nc2c(F)cc(-c3nc(Nc4ccc(N5CCCC5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 18/20 0.68
CDK6 Q00534 15/20 0.68
CDK2 P24941 12/20 0.68
CDK1 P06493 10/20 0.68
CCNE1 P24864 7/20 0.68
CCND3 P30281 6/20 0.68
CCNB1 P14635 6/20 0.68
CDK7 P50613 5/20 0.68
CDK9 P50750 5/20 0.68
CCNA2 P20248 3/20 0.68
EGFR P00533 2/20 0.68
CCNT1 O60563 2/20 0.68
CCNH P51946 2/20 0.68
CIT O14578 1/20 0.68
GAK O14976 1/20 0.68
DYRK3 O43781 1/20 0.68
STK16 O75716 1/20 0.68
CCNK O75909 1/20 0.68
STK10 O94804 1/20 0.68
PRKD3 O94806 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488826 0.93 CDK4 (0.67) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL30459608 0.93 CDK6 (0.69) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL30459609 0.93 CDK6 (0.69) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17488831 0.93 CDK6 (0.69) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17488713 0.92 CDK4 (0.63) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17489154 0.91 CDK4 (0.64) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17488701 0.91 CDK4 (0.64) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17488716 0.91 CDK4 (0.64) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17488669 0.91 CDK4 (0.61) CDK4CDK6CDK2CDK1CCNE1
SCHEMBL17489296 0.91 CDK4 (0.61) CDK4CDK6CDK2CDK1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed